NCT01135797 - Retrospective Safety Survey In Patients Included In NV1FGF Clinical Trials | Biotech Hunter

Enrollment

164

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Peripheral Arterial Occlusive Disease

Trial Locations (7)

Sanofi-Aventis Administrative Office, Bridgewater

Sanofi-Aventis Administrative Office, Diegem

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, Berlin

Sanofi-Aventis Administrative Office, Milan

Sanofi-Aventis Administrative Office, Geneva

Sanofi-Aventis Administrative Office, Guildford Surrey